Two healthcare stocks, Amgen and AbbVie, offer attractive dividends and strong growth potential
From Yahoo Finance: 2025-04-05 08:30:00
Investors often shy away from healthcare stocks due to a lack of reliable dividend payers. However, Amgen and AbbVie stand out with attractive dividend policies. Amgen saw a strong year in 2024, with revenue up 19% to $33.4 billion despite higher costs. Amgen recently raised its dividend by 6% to $2.38 per share, offering a 3% yield. AbbVie also prioritizes dividends, with a 6% increase to $1.64 per share and a consistent track record of raises over 25 years. Both companies have diverse portfolios and strong pipelines for future growth. AbbVie forecasts high single-digit revenue growth through 2029 and expects combined sales of Rinvoq and Skyrizi to reach $31 billion by 2027. Consider these factors before investing in Amgen.